Skip to main content
. 2019 Nov 18;53(6):423–431. doi: 10.1007/s13139-019-00624-8

Fig. 2.

Fig. 2

Ga68-PSMA PET-CT maximum intensity projection pre (a) and 8 weeks post (b) Lu-177-PSMA therapy images showed stable disease. This 68 years old prostate cancer patient earlier treated with bilateral orchidectomy, multiple lines of anti-androgens including abiraterone, enzalutamide and two lines of chemotherapy docetaxel and cabazitaxel. Pre and 8 weeks post Lu-177-PSMA therapy, PSA showed stable disease (396.6 ng/ml vs 344 ng/ml)